NOCIL Q1 FY26: Flat revenue, margin pressure, and a clear fight against dumping

NOCIL opened FY26 with a steady top line but softer profitability. Consolidated revenue from operations for Q1 FY26 came in at INR 336 crore, broadly flat versus INR 340 crore in Q4 FY25. Operating EBITDA declined to INR 31 crore, translating to a 9.1% margin, and profit after tax fell to INR 17 crore (vs INR 21 crore in the previous quarter).

Management framed the quarter as a balancing act. Export volumes continued to grow, supported by incremental customer approvals across geographies. But the domestic market remained under heavy dumping pressure, forcing the company to take a “judicious mix of price and volume” decisions to protect relationships while staying competitive.

What changed in the quarter: exports helped, domestic pricing hurt

Two threads ran through the call. The first was domestic market stress. NOCIL stated it continues to experience dumping pressure in India and has responded by filing antidumping petitions on select key products. The Government of India has initiated detailed investigations after finding merit, and management expects an outcome in the coming months.

The second thread was exports. The company said export momentum remains intact and is being supported by incremental approvals from international customers across multiple locations. However, export volume growth in Q1 FY26 moderated to about 3% to 3.5%, largely due to temporary weakness in latex-linked demand in Southeast Asia amid evolving United States tariff developments.

Financial snapshot (Q1 FY26 vs Q4 FY25)

Note: Q4 FY25 EBITDA margin was not stated in the transcript provided.

Antidumping: a potential reset lever, but still early

The most material strategic update in the call was the antidumping process. NOCIL stated it has filed petitions on some key products to counter domestic dumping. The government has initiated investigations, but management did not quantify potential benefits, stating it is premature while the matter is under review.

Two important data points were shared. First, the products under antidumping investigation represent around 40% of the business, implying that any favorable outcome could be meaningful for the domestic profitability profile. Second, management clarified the investigation is not for all previously covered products, and named key antioxidants such as Pilflex 13 and Pilnox TDQ, along with a set of sulphenamides.

Even if duties are imposed, the implication is unlikely to be an overnight jump. Pricing, contract structures, and customer inventories typically delay the translation of policy changes into margins. Still, the decision to pursue formal trade remedies signals that the company sees dumping as persistent enough to warrant regulatory intervention.

Costs, inventories, and conversion expenses: what management said

On operating costs, management addressed two specific items.

One was conversion cost. The Chief Financial Officer stated conversion costs appeared higher because production activity during the quarter was higher, with intermediate and finished goods production up about 15% to 20% sequentially. The company also front-loaded about 60% of its annual statutory corporate social responsibility spending into Q1, which weighed on quarterly costs.

The second was raw material pricing, especially aniline. Management said most of the benefit from lower aniline prices has already been captured in Q1 FY26, with only a small residual impact possibly pending in Q2 through finished goods. They also explained that the stock-change effect did not show a larger credit because raw material prices were falling, reducing the accounting value of inventory.

Utility costs also came up. Management said a turbine has been commissioned, and once stabilization issues are addressed, it is expected to become a significant saver for utility costs. However, they declined to quantify the savings, calling it commercially sensitive.

Capacity utilization and the next growth leg: Dahej capex and approvals

NOCIL stated current capacity utilization is around 65% to 67% on an overall basis. Management emphasized this is an average across multiple products, with some product lines having more headroom than others.

The longer-term growth lever is the company’s capex plan. Management discussed a budget of about INR 250 crore, with around 30% spent as of March 2025. This spending is currently in capital work in progress and the project is not yet commissioned.

The timeline provided was clear:

• Trial production is expected to start during H1 FY26-27.
• After trials and customer approvals, revenues are expected to begin in H2 FY27.

This guidance matters because the demand capture is not only about installing equipment. In rubber chemicals, customers require site approvals, and management explicitly said that even for products with strong demand visibility, the ramp-up needs patience due to the approval cycle.

Market context: tire growth, tariffs, and supply-chain derisking

Management expects the Indian tire industry to grow at mid-single digits, driven by replacement demand and aided by infrastructure-led demand for commercial vehicle tires. It also noted the domestic auto component industry should grow, albeit slower than last year, while warning that evolving United States tariff scenarios could affect end markets.

Internationally, management said replacement demand in tires is showing a slight positive uptick in most markets. However, latex markets in Southeast Asia have faced temporary uncertainty linked to tariffs.

A key positive theme was customer derisking away from China. Management reiterated that some global customers are actively implementing “China plus one” sourcing strategies rather than treating it as lip service. NOCIL also described itself as favorably positioned due to scale, backward integration, and being a non-Chinese supplier in some products.

Another notable disclosure was the company’s exposure to the United States. Management stated the U.S. contributes about 4% to 5% of the business and indicated a wait-and-watch approach, while working on alternate customer avenues in Europe, Asia, and Latin America.

Closing takeaways

NOCIL’s Q1 FY26 was defined by stable revenue and pressured profitability, with domestic dumping acting as the central constraint. Exports continued to add resilience, but tariff-linked uncertainty in certain latex-linked markets tempered export growth in the quarter.

The next 12 to 24 months will likely be shaped by three moving parts: the outcome of antidumping investigations, the pace of utilization improvement at existing assets, and execution of the Dahej capex with the associated customer approval cycle. Management’s commentary suggests the company is working multiple levers in parallel, but the timing of a visible step-up in earnings will depend heavily on market conditions and regulatory outcomes.